ArticleERJ open research2026
The impact of positive airway pressure treatment on mortality and hospitalisation in obstructive sleep apnoea: a German database analysis.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnoea (OSA) is a prevalent disorder. No consistent mortality benefit from treating OSA has been reported in randomised controlled trials. This analysis of an age-and-sex-representative anonymised German public health insurance database from 2015-2020 investigated mortality and hospitalisation rates in positive airway pressure (PAP)-treated Methods: Treatment-naïve individuals with OSA were selected and stratified by PAP prescription (PAP treated Results: The mortality analysis included 12 297 PAP and 10 020 non-PAP-treated individuals. During a mean 4.0 years of follow-up, 1067 people (4.8%) died; the mortality rate was significantly lower in the PAP Conclusion: In this comprehensive analysis, PAP therapy was associated with lower mortality and fewer hospitalisations during the follow-up period compared with no PAP therapy, though residual confounding and the observational nature of the study should be considered when interpreting the results.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.